TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22690855

Group type: EXPERIMENTAL
Intervention: Whole linseeds (2 tablespoons per day), n = 11
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ground linseeds (2 tablespoons per day), n = 11
Number of subjects: 40

Group type: COMPARATOR
Intervention: Whole linseeds (2 tablespoons per day), n = 9
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ground linseeds (2 tablespoons per day), n = 13
Number of subjects: 40
Study: 20002592

Group type: EXPERIMENTAL
Intervention: Optimized antidepressant therapy for both depression and pain
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 250
Study: 17658026

Group type: EXPERIMENTAL
Intervention: Double-channel gastroscope and foreign body forceps plus symmetrical polypectomy shark retrieval snare
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard gastroscope and foreign body forceps
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard gastroscope and retrieval snare
Number of subjects: 87
Study: 16219273

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 47

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 47
Study: 12201325

Group type: EXPERIMENTAL
Intervention: eZ.on condom
Number of subjects: 43

Group type: COMPARATOR
Intervention: Gossamer condom (control)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Avanti condom (control)
Number of subjects: 43
Study: 10512093

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 0
Study: 7572748

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (55% of energy as carbohydrate and 30% as fat)
Number of subjects: 10

Group type: COMPARATOR
Intervention: High-monounsaturated-fat diet (45% of energy as fat and 40% as carbohydrates)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet
Number of subjects: 10
Study: 2145237

Group type: EXPERIMENTAL
Intervention: Enoximone, 100 mg t.d.s. added to optimal therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 352140

Group type: EXPERIMENTAL
Intervention: Carbenoxolone
Number of subjects: 29
Study: 30936865

Group type: EXPERIMENTAL
Intervention: Dairy protein supplement (6 grams/packet, twice per day for 8 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Soy protein supplement (6 grams/packet, twice per day for 8 weeks)
Number of subjects: 0
Study: 27614706

Group type: EXPERIMENTAL
Intervention: One-shot dilation (OSD)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Balloon dilation (BD)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Sequential Amplatz dilation
Number of subjects: 480

Group type: COMPARATOR
Intervention: Telescopic Alken dilation
Number of subjects: 480
Study: 26032480

Group type: COMPARATOR
Intervention: Mental health intervention with a wait list control
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Community consultation
Number of subjects: 19
Study: 23514955

Group type: EXPERIMENTAL
Intervention: Campaign approach among health workers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control district (no intervention)
Number of subjects: 0
Study: 21462258

Group type: EXPERIMENTAL
Intervention: Internal cue (attention to increase step length)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: External cue (auditory cue with instruction to take large step to the beat)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dopaminergic medications
Number of subjects: 50
Study: 19788967

Group type: EXPERIMENTAL
Intervention: Duration of second stage of labor <1 hour
Number of subjects: 4126

Group type: EXPERIMENTAL
Intervention: Duration of second stage of labor >=5 hours
Number of subjects: 4126

Group type: EXPERIMENTAL
Intervention: Duration of second stage of labor
Number of subjects: 4126
Study: 16037752

Group type: EXPERIMENTAL
Intervention: Combined esterified estrogens (1.25 mg) and methyltestosterone (2.5 mg) (EE/MT)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Esterified estrogens (1.25 mg) alone (EE)
Number of subjects: 102
Study: 12151959

Group type: EXPERIMENTAL
Intervention: Topotecan 1.5 mg/m2 days 1-3 and vinorelbine 25 mg/m2 days 1 and 8 without filgrastim
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Topotecan 1.5 mg/m2 days 1-3 and vinorelbine 25 mg/m2 days 1 and 8 with filgrastim
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Topotecan plus vinorelbine (both with and without filgrastim)
Number of subjects: 5
Study: 10065780

Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg/d; n = 14)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: CPA (25 mg plus ethinyl E2 (EE); n = 13)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Flutamide (500 mg/d; n = 15)
Number of subjects: 45
Study: 8640470

Group type: EXPERIMENTAL
Intervention: Non-suture method (Monsel's solution pack)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Suture method
Number of subjects: 142
Study: 2307870

Group type: EXPERIMENTAL
Intervention: Excision and skin closure with a rotation flap
Number of subjects: 35

Group type: COMPARATOR
Intervention: Simple excision
Number of subjects: 35
Study: 6778456

Group type: COMPARATOR
Intervention: Sodium valproate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sodium valproate in combination with low doses of lithium
Number of subjects: 12
Study: 30770294

Group type: EXPERIMENTAL
Intervention: Enzalutamide (160 mg per day)
Number of subjects: 1401
Study: 27488837

Group type: EXPERIMENTAL
Intervention: Modified Epley maneuver
Number of subjects: 73

Group type: COMPARATOR
Intervention: Gans maneuver
Number of subjects: 73
Study: 23414086

Group type: EXPERIMENTAL
Intervention: WEB + SN + NRT
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: WEB + NRT
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: WEB + SN
Number of subjects: 4000

Group type: COMPARATOR
Intervention: WEB
Number of subjects: 4000
Study: 21825897

Group type: EXPERIMENTAL
Intervention: Tissue sealing‐cutting device
Number of subjects: 128

Group type: COMPARATOR
Intervention: Monopolar electrocautery
Number of subjects: 128
Study: 19899545

Group type: EXPERIMENTAL
Intervention: Bimatoprost
Number of subjects: 0
Study: 16723322

Group type: EXPERIMENTAL
Intervention: Early-stage PD group
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Advanced-stage PD group
Number of subjects: 41

Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 41
Study: 16246943

Group type: EXPERIMENTAL
Intervention: Applied Kinesiology (AK)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Open test phase
Number of subjects: 81
Study: 12404166

Group type: EXPERIMENTAL
Intervention: Live, attenuated human rotavirus vaccine 89-12
Number of subjects: 184
Study: 10335001

Group type: EXPERIMENTAL
Intervention: Budesonide (400 microg twice daily)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Terbutaline (1 mg four times daily)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Combined treatment (Budesonide and Terbutaline)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 7567317

Group type: EXPERIMENTAL
Intervention: Ceftibuten oral suspension at a dose of 9.0 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ceftibuten oral suspension at doses of 4.5, 9.0, and 13.5 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ceftibuten oral suspension
Number of subjects: 0
Study: 2343787

Group type: EXPERIMENTAL
Intervention: Exposure to alcohol cues (sight and smell of favorite alcoholic drink)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Negative mood states
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Relaxation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Neutral mood state
Number of subjects: 8
Study: 7400486

Group type: EXPERIMENTAL
Intervention: Feingold's K-P diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 0
Study: 31944893

Group type: EXPERIMENTAL
Intervention: Dental RECUR Brief Negotiated Interview for Oral Health (DR‐BNI)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Control intervention (parent‐nurse conversation about child's future tooth eruption)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: DR‐BNI group
Number of subjects: 241
Study: 29882725

Group type: EXPERIMENTAL
Intervention: Current safety measures at HWZs in Pakistan
Number of subjects: 0

Group type: COMPARATOR
Intervention: MUTCD safety procedures
Number of subjects: 0
Study: 29197345

Group type: COMPARATOR
Intervention: Etoricoxib 120 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Duloxetine 60 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg and Etoricoxib 120 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 25516371

Group type: EXPERIMENTAL
Intervention: Guanfacine (3 mg/day)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (0 mg/day)
Number of subjects: 33
Study: 24361199

Group type: EXPERIMENTAL
Intervention: Lower extremity vein bypass grafts (LEVBGs) with duplex ultrasound (DUS) surveillance
Number of subjects: 1404

Group type: EXPERIMENTAL
Intervention: Nonadherence with ultrasound surveillance
Number of subjects: 1404

Group type: EXPERIMENTAL
Intervention: Graft diameter <3 mm
Number of subjects: 1404

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 1404
Study: 21362724

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol (1 g)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Intravenous morphine (10 mg)
Number of subjects: 55
Study: 19666639

Group type: EXPERIMENTAL
Intervention: Warfarin suspended 3 days before surgery (Group 1)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Warfarin suspended <3 days or not at all (Group 2)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Post-operation heparin treatment
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Proposed protocol of perioperative anticoagulation (suspension of warfarin not <3 days with low-molecular-weight heparin bridging stopped 12 h before surgery)
Number of subjects: 109
Study: 17203292

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg oral dose (PO)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg intravenous dose (IV)
Number of subjects: 20
Study: 15213052

Group type: EXPERIMENTAL
Intervention: Red wine (30 g ethanol/d for 28 days)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Gin (30 g ethanol/d for 28 days)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Washout period
Number of subjects: 8
Study: 11737928

Group type: EXPERIMENTAL
Intervention: Untreated obstructive sleep apnea (OSA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Evidence of subtle functional vascular abnormalities
Number of subjects: 0
Study: 9532989

Group type: EXPERIMENTAL
Intervention: Low dose aspirin
Number of subjects: 6275

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6275
Study: 7978172

Group type: EXPERIMENTAL
Intervention: 4 mg ondansetron
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1.25 mg droperidol
Number of subjects: 40
Study: 2686489

Group type: EXPERIMENTAL
Intervention: O2/N2 (1:1)
Number of subjects: 42

Group type: COMPARATOR
Intervention: O2/N2O (1:1)
Number of subjects: 42
Study: 29232214

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided corticosteroid injection above the median nerve
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ultrasound-guided corticosteroid injection below the median nerve
Number of subjects: 44
Study: 26149961

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT with tension)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham (KT without tension)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (no taping)
Number of subjects: 28
Study: 24794514

Group type: EXPERIMENTAL
Intervention: CSP and wavelet filtering (WF) for VEP detection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online BCI system using the proposed approach
Number of subjects: 0
Study: 22022927

Group type: EXPERIMENTAL
Intervention: Guidance provided to mothers during pregnancy and when the child was 6 and 12 months old
Number of subjects: 625

Group type: COMPARATOR
Intervention: Comparison group of similar school children
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 625

Group type: COMPARATOR
Intervention: Comparison group of school children
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Both randomized groups
Number of subjects: 625
Study: 20519561

Group type: EXPERIMENTAL
Intervention: DASH dietary pattern
Number of subjects: 372
Study: 18075766

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 16219731

Group type: EXPERIMENTAL
Intervention: Visual impairment (binocular visual acuity <6/18 or <20/60 Snellen)
Number of subjects: 13569

Group type: EXPERIMENTAL
Intervention: Visual impairment due to cataract or age-related macular degeneration
Number of subjects: 13569

Group type: EXPERIMENTAL
Intervention: Visual impairment due to refractive error
Number of subjects: 13569

Group type: COMPARATOR
Intervention: Cancer mortality
Number of subjects: 13569
Study: 12433764

Group type: EXPERIMENTAL
Intervention: Nurse led follow up
Number of subjects: 203
Study: 10342407

Group type: EXPERIMENTAL
Intervention: Opioids (specific dosage and duration not mentioned)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active placebo mimicking side-effects
Number of subjects: 0
Study: 7739306

Group type: EXPERIMENTAL
Intervention: 585 nm flashlamp‐pumped pulsed‐dye laser treatment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Untreated areas of scar
Number of subjects: 16
Study: 2188905

Group type: EXPERIMENTAL
Intervention: 14 days regimen of diethyl carbamazine (DEC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5 days regimen of diethyl carbamazine (DEC)
Number of subjects: 0
Study: 7380759

Group type: EXPERIMENTAL
Intervention: Contingent-awakening and breathing retraining (self-control) condition
Number of subjects: 24

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 24
Study: 30927415

Group type: EXPERIMENTAL
Intervention: hCG trigger (5000 IU)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: GnRHa trigger (buserelin 0.5 mg)
Number of subjects: 384
Study: 29467392

Group type: EXPERIMENTAL
Intervention: Alcohol beverage (PostBev)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo beverage (PostBev)
Number of subjects: 15
Study: 26742509

Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate (PP) - 78‐234 mg, monthly injectable
Number of subjects: 444

Group type: COMPARATOR
Intervention: Oral antipsychotics (OA) - daily treatment
Number of subjects: 444
Study: 23795823

Group type: EXPERIMENTAL
Intervention: Multi‐Family Psychoeducational Psychotherapy (MF‐PEP)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 165
Study: 22443173

Group type: EXPERIMENTAL
Intervention: Metformin (250 mg per day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20226144

Group type: EXPERIMENTAL
Intervention: Bushen Huoxue Granule (BSHXG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 17919541

Group type: EXPERIMENTAL
Intervention: Inhaled zanamivir 10 mg once daily for 28 days
Number of subjects: 3363

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3363
Study: 16208616

Group type: EXPERIMENTAL
Intervention: CABG surgery
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Heart valve surgery
Number of subjects: 112

Group type: COMPARATOR
Intervention: Preoperative evaluation
Number of subjects: 112
Study: 11872977

Group type: EXPERIMENTAL
Intervention: Nurse-led education and support
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional patient education by physician
Number of subjects: 20
Study: 10915082

Group type: EXPERIMENTAL
Intervention: 5-day oral antibiotics
Number of subjects: 4782

Group type: COMPARATOR
Intervention: 10-day penicillin V
Number of subjects: 4782
Study: 8955760

Group type: EXPERIMENTAL
Intervention: Ibopamine 100 mg/day (group A)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Control (group B)
Number of subjects: 189
Study: 4000532

Group type: EXPERIMENTAL
Intervention: Tiropramide hydrochloride 100 mg t.i.d. for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31056840

Group type: EXPERIMENTAL
Intervention: 10 mg danirixin hydrobromide
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 50 mg danirixin hydrobromide
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 100 mg danirixin hydrobromide
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 50 mg danirixin hydrobromide (fed state - low-fat meal)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (fasted state)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Overall safety profile of danirixin
Number of subjects: 34
Study: 29596127

Group type: EXPERIMENTAL
Intervention: Early postoperative feeding
Number of subjects: 92

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 92
Study: 27816118

Group type: EXPERIMENTAL
Intervention: CK-MB elevation in the first 24 hours after CABG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New Q waves post-CABG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New Q waves (when CK-MB is excluded)
Number of subjects: 0
Study: 25114912

Group type: EXPERIMENTAL
Intervention: Dietary nitrate supplementation for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23528001

Group type: EXPERIMENTAL
Intervention: Search display interrupted with a blank screen during visual search tasks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Half the distractors were blue and half were yellow in Experiment 2.
Number of subjects: 0
Study: 19478822

Group type: EXPERIMENTAL
Intervention: Surgery (macular relocation)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (observation or photodynamic therapy)
Number of subjects: 28
Study: 17963760

Group type: EXPERIMENTAL
Intervention: Iron supplementation (ferrous sulfate tablet containing 50 mg elemental iron daily)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 66
Study: 16816276

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention including psychoeducation, simplified practice guidelines, and nurse care coordinator support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 14641799

Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg) once daily for five consecutive days
Number of subjects: 441

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 441
Study: 10985708

Group type: EXPERIMENTAL
Intervention: Angiography
Number of subjects: 1159

Group type: COMPARATOR
Intervention: No angiography
Number of subjects: 1159
Study: 8774094

Group type: EXPERIMENTAL
Intervention: Ultrasound screening
Number of subjects: 9310
Study: 1593553

Group type: EXPERIMENTAL
Intervention: Daily vaginal suppositories of 10 mg of prostaglandin E2 (17 patients)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Daily intravesical solution of 50 micrograms of prostaglandin F2 alpha dissolved in 100 mL of normal saline (15 patients)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Daily instillation of 100 mL of saline (18 patients)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 50
Study: 31833064

Group type: COMPARATOR
Intervention: Standard systolic blood pressure management (130-150 mmHg)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Augmented systolic blood pressure management (160-180 mmHg)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 51
Study: 31062541

Group type: EXPERIMENTAL
Intervention: High-intensity aerobic interval training (two sessions per week, four 4-minute intervals at 85-95% HRmax with 3-minute active breaks at 70% HRmax)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 12
Study: 27992112

Group type: EXPERIMENTAL
Intervention: BAY 94-9027 (25 IU kg-1 body weight two times per week for 10 weeks, then 30-40 IU kg-1 two times per week or randomized to every-5-days (45-60 IU kg-1) or every-7-days (60 IU kg-1) prophylaxis for 26 weeks)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: BAY 94-9027 (every-5-days treatment)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: BAY 94-9027 (every-7-days prophylaxis)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: BAY 94-9027
Number of subjects: 132
Study: 25530148

Group type: EXPERIMENTAL
Intervention: Treatment participants (SPs)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control participants (SPs)
Number of subjects: 58
Study: 23387374

Group type: EXPERIMENTAL
Intervention: 2% tofacitinib ointment 1
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 2% tofacitinib ointment 2
Number of subjects: 71

Group type: COMPARATOR
Intervention: vehicle 1
Number of subjects: 71

Group type: COMPARATOR
Intervention: vehicle 2
Number of subjects: 71
Study: 21429214

Group type: EXPERIMENTAL
Intervention: HDC/IL‐2 treatment
Number of subjects: 320

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 320
Study: 19320915

Group type: EXPERIMENTAL
Intervention: Risk-based oral health programme (OHP) targeting MS-positive subjects, involving repeated health education for caretakers and xylitol lozenges for children.
Number of subjects: 794

Group type: COMPARATOR
Intervention: Traditional oral health programme (control group).
Number of subjects: 794
Study: 18081669

Group type: EXPERIMENTAL
Intervention: Booster evaluation group
Number of subjects: 277

Group type: COMPARATOR
Intervention: Control group (no booster evaluation)
Number of subjects: 277
Study: 15712727

Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 3DUS
Number of subjects: 9
Study: 11240075

Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg bid
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dihydrocodeine 60 mg bid
Number of subjects: 60

Group type: COMPARATOR
Intervention: NSAIDs alone
Number of subjects: 60
Study: 9874916

Group type: EXPERIMENTAL
Intervention: Mild head injury (HI)
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Other injuries
Number of subjects: 339

Group type: COMPARATOR
Intervention: No injury (NI)
Number of subjects: 339
Study: 8033491

Group type: EXPERIMENTAL
Intervention: MK-0591 250 mg every morning for 10 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MK-0591 50 mg every morning for 10 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MK-0591 125 mg every morning for 10 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MK-0591 250 mg every 12 hours for 10 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MK-0591 (all doses)
Number of subjects: 0